Investigator

Jun Lyu

Professor / Ph.D. Supervisor / Director · First Affiliated Hospital of Jinan University, Department of Clinical Research

About

JLJun Lyu
Papers(1)
Causes of death in en…
Collaborators(1)
Qing Xue
Institutions(2)
First Affiliated Hosp…Jinan Central Hospital

Papers

Causes of death in endometrial cancer survivors: A Surveillance, Epidemiology, and End Result–based analysis

AbstractBackgroundIncreasing attention has been paid to the survival of endometrial cancer (EC) patients, but the non‐cancer causes of death from EC are rarely reported. This study primarily aimed to investigate the non‐cancer causes of death in patients with EC.MethodsThe study collected relevant data, including age, tumour stage and treatment mode, on patients diagnosed with endometrial malignancies from 2000 to 2015 in the Surveillance, Epidemiology, and End Results (SEER) Programme. We analysed the standardised mortality ratio (SMR) to determine the cause of death.ResultsThe study included 135,831 patients with EC. During the follow‐up, 46,604 (34.3%) patients died, of whom 42.9%, 15.6% and 41.5% died of EC, other cancers and non‐cancer causes, respectively. As the diagnosis time increased, the number of EC‐associated mortalities gradually decreased. The most common non‐cancer causes of death were heart disease, cerebrovascular disease and diabetes. Regarding the general population of the United States, patients with EC died of heart disease (SMR: 1.06; 95% confidence interval [CI]: 1.03–1.09), diabetes (SMR: 1.56; 95% CI: 1.47–1.65) and septicaemia (SMR: 1.40; 95% CI: 1.28–1.52), which were statistically significant.ConclusionsFor patients with EC, the number of deaths from non‐cancer causes (mainly heart disease, cerebrovascular disease and diabetes mellitus) is equivalent to that of EC. In addition, compared with the general population, EC survivors have a higher risk of death from sepsis and diabetes. These discoveries support how survivors can avoid future‐related health risks. By doing this, clinicians can improve the quality of life and chances of the survival of patients with EC.

480Works
1Papers
1Collaborators
PrognosisNeoplasm StagingCarcinoma, Squamous CellGlobal Burden of DiseaseAlzheimer DiseaseCardiovascular DiseasesLung Neoplasms

Positions

2020–

Professor / Ph.D. Supervisor / Director

First Affiliated Hospital of Jinan University · Department of Clinical Research

2014–

Associate Professor / Ph.D. Supervisor / Deputy Director

First Affiliated Hospital of Xi'an Jiaotong University · Clinical Research Center

2010–

Associate Professor

First Affiliated Hospital of Xi'an Jiaotong University · Department of Pharmacy

2008–

Postdoc

Fourth Military Medical University · Department of Pharmacy

Education

2006

M.D., Ph.D.

Xi'an Jiaotong University School of Medicine · Department of Pharmacology

2001

Bachelor of Medicine

Xi'an Jiaotong University School of Medicine · Department of Medicine

Country

CN

Links & IDs
0000-0002-2237-8771Homepage1Homepage2

Scopus: 57194336419

Researcher Id: AAS-1229-2021